ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Cuiping Wang
Matched on ORCID iD 0000-0001-5059-5880; OpenAlex author ID A5108052788. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2015: 3 papers · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper
Papers 6
- Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals. Last author DOI 10.1042/bsr20190610↗
- Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1177/1533034618754475↗
- Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing. Co-author DOI 10.3892/ijo.2018.4560↗
- Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-3690-x↗
- MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. Co-author DOI 10.1371/journal.pone.0119783↗
- Correction: MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2. Co-author DOI 10.1371/journal.pone.0128257↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shuangni Yu · 5 shared papers, 2015–2018 · strength 0.34
- Paper Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequen… DOI 10.3892/ijo.2018.4560↗
- Paper Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenoc… DOI 10.1177/1533034618754475↗
- Paper MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. DOI 10.1371/journal.pone.0119783↗
- Congwei Jia · 4 shared papers, 2015–2018 · strength 0.30
- Paper Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequen… DOI 10.3892/ijo.2018.4560↗
- Paper Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenoc… DOI 10.1177/1533034618754475↗
- Paper MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. DOI 10.1371/journal.pone.0119783↗
- Jie Chen · 3 shared papers, 2015–2018 · strength 0.23
- Paper Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequen… DOI 10.3892/ijo.2018.4560↗
- Paper Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenoc… DOI 10.1177/1533034618754475↗
- Paper Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3690-x↗
- Peng Chen · 1 shared paper, 2019 · strength 0.16
- Yang Sun · 3 shared papers, 2015 · strength 0.16
- Paper MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. DOI 10.1371/journal.pone.0119783↗
- Paper Correction: MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2. DOI 10.1371/journal.pone.0128257↗
- Paper Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3690-x↗
- Li Zhang · 2 shared papers, 2015–2018 · strength 0.14
- Paper Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequen… DOI 10.3892/ijo.2018.4560↗
- Paper Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3690-x↗
- Xianglan Jin · 2 shared papers, 2015 · strength 0.11
- Jie Chen · 2 shared papers, 2015 · strength 0.11
- Tingting Zhang · 2 shared papers, 2015 · strength 0.11
- Li Zhang · 1 shared paper, 2018 · strength 0.09
- Pingping Liu · 1 shared paper, 2015 · strength 0.05
- Huanwen Wu · 1 shared paper, 2015 · strength 0.05
- Yunxiao Meng · 1 shared paper, 2015 · strength 0.05
- Mingyang Liu · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.